Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy E Albertson

Showing results (21-30 of 126) with videos related to

Pageof 13
Sort By:
Clinical Reviews in Allergy & Immunology|May 30, 2013
Marijuana: respiratory tract effectsKelly P Owen, Mark E Sutter, Timothy E Albertson
Current Infectious Disease Reports|March 15, 2012
Are fluoroquinolones superior antibiotics for the treatment of community-acquired pneumonia?Timothy E Albertson, Brian M Morrissey, Andrew L Chan
The Journal of Emergency Medicine|December 3, 2014
Beta-blocker use for toxicity from "bath salts"John R Richards, Erik G Laurin, Timothy E Albertson
Therapeutic Advances in Respiratory Disease|December 16, 2015
The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experienceTimothy E Albertson, John R Richards, Amir A Zeki
British Journal of Clinical Pharmacology|July 16, 2015
Treatment of drug-induced seizuresHsien-Yi Chen, Timothy E Albertson, Kent R Olson
Journal of Biomedical Research|November 29, 2013
Pulmonary cystic disease associated with integumentary and renal manifestationsKatherine S Cayetano, Timothy E Albertson, Andrew L Chan
Clinical Reviews in Allergy & Immunology|September 13, 2014
The acute management of asthmaTimothy E Albertson, Mark E Sutter, Andrew L Chan
Critical Care Clinics|May 31, 2021
Carbon Monoxide PoisoningJames A Chenoweth, Timothy E Albertson, Matthew R Greer
Annals of Thoracic Medicine|June 7, 2013
Cerebral gas embolism in a case of Influenza A-associated acute respiratory distress syndrome treated with high-frequency oscillatory ventilationChristian M Sebat, Timothy E Albertson, Brian M Morrissey
Patient Preference and Adherence|February 13, 2015
Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterolTimothy E Albertson, Richart Harper, Susan Murin, et al.
Pageof 13

Showing results (21-30 of 126) with videos related to

Sort By:
Pageof 13
Clinical Reviews in Allergy & Immunology|May 30, 2013
Marijuana: respiratory tract effectsKelly P Owen, Mark E Sutter, Timothy E Albertson
Current Infectious Disease Reports|March 15, 2012
Are fluoroquinolones superior antibiotics for the treatment of community-acquired pneumonia?Timothy E Albertson, Brian M Morrissey, Andrew L Chan
The Journal of Emergency Medicine|December 3, 2014
Beta-blocker use for toxicity from "bath salts"John R Richards, Erik G Laurin, Timothy E Albertson
Therapeutic Advances in Respiratory Disease|December 16, 2015
The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experienceTimothy E Albertson, John R Richards, Amir A Zeki
British Journal of Clinical Pharmacology|July 16, 2015
Treatment of drug-induced seizuresHsien-Yi Chen, Timothy E Albertson, Kent R Olson
Journal of Biomedical Research|November 29, 2013
Pulmonary cystic disease associated with integumentary and renal manifestationsKatherine S Cayetano, Timothy E Albertson, Andrew L Chan
Clinical Reviews in Allergy & Immunology|September 13, 2014
The acute management of asthmaTimothy E Albertson, Mark E Sutter, Andrew L Chan
Critical Care Clinics|May 31, 2021
Carbon Monoxide PoisoningJames A Chenoweth, Timothy E Albertson, Matthew R Greer
Annals of Thoracic Medicine|June 7, 2013
Cerebral gas embolism in a case of Influenza A-associated acute respiratory distress syndrome treated with high-frequency oscillatory ventilationChristian M Sebat, Timothy E Albertson, Brian M Morrissey
Patient Preference and Adherence|February 13, 2015
Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterolTimothy E Albertson, Richart Harper, Susan Murin, et al.
Pageof 13